Spatial Unveils Latest Updates Across Key Product Lines, Delivering Enhanced Performance, Workflow Efficiency, and Automation Capabilities
19.11.2024 23:00:00 CET | Business Wire | Press release
Spatial Corp., the leading 3D software development toolkit provider for design, manufacturing and engineering solutions and a subsidiary of Dassault Systèmes, announces the 2025 release and updates across several product lines, reaffirming its commitment to providing innovative solutions for its customers in domains ranging from CAD to simulation, manufacturing, and beyond.
The 2025 release and updates include:
3D InterOp: Improved Performance and New Functionality
- Performance Improvements of 3D Data Import: Fine-tuned parallel processing combined with format-specific reader optimizations deliver significant reductions in import times. Specifically, improvements are seen in many formats including IGES, STEP, Inventor, Solid Edge, Creo, SOLIDWORKS, and Navisworks, with SOLIDWORKS import times reduced by up to 50% and average performance gains of 22% for Solid Edge and 24% for Inventor. For files that do not contain native visualization, the performance of faceting imported BREP has improved by an average of 25% in formats like STEP, IGES, and Parasolid. This accelerates workflows that rely on previews such as design reviews, technical documentation, and VR applications.
- Optimization of Memory Usage During Imports: In this release, memory consumption and growth have been reduced, particularly for SOLIDWORKS imports. In one test case, reductions in peak pagefile usage were observed of 30% for a single translation and 78% for 2,000 translations in succession. This improvement enables handling of larger, more complex models and increases the number of operations that can run in batch processes, both on desktops and servers.
- Support Assembly Cut Features from within the SOLIDWORKS Reader: Accurate import of assembly cuts, such as extruded holes and cutouts, preserves design intent and eliminates the need for manual adjustments post-import. This enhancement was initially introduced for the 3D InterOp Creo Reader and is now extended to SOLIDWORKS.
- Data Prep Add-On: Ongoing Commitment to Development: This update includes performance and robustness improvements to enhance the data preparation experience. In addition, the part-level Hidden Body Removal feature is now available for testing with assembly-level coming soon. This functionality allows users to streamline their workflow by filtering out unnecessary components at the part level.
3D ACIS Modeler: Automating Complex Metalworking Tasks and Slice Operations Performance Improvements
- Automatic Unbending: This new API automatically detects bends in sheet metal bodies and unfolds them. The API allows developers to integrate unfolding functionality quickly in their CAM applications.
- Performance Improvements for Slice Operations: Two new APIs improve slicing performance by up to 60% for solid bodies and up to 50% for sheet bodies, accelerating the overall design and manufacturing workflow.
CGM Modeler: The Mid-Surface Operator Now Includes an Absolute Offset Mode
This new mode generates a mid-surface by offsetting the faces on one side of the body. This algorithm is designed to be robust and performant for parts with uniform thickness.
CSM-CVM: Improved Robustness and Volume Proximity Layer Generation
- Meshing Improvements for CSM: In this release, mesh quality has been improved for sliver faces. In January 2025, surface anisotropic ratio control will be made available.
- Volume Proximity Layer Generation Enhancement: Enhanced volume proximity layer generation simplifies the creation of consistent meshing layers in thin sections, eliminating the need for manual sizemaps. This benefits industries such as plastic injection molding and chip design by improving meshing consistency.
Support for Linux ARM
Beginning with this release, Spatial now supports Linux ARM for the 3D modelers ACIS and CGM as well as CSM-CVM and CDS. Spatial also supports a pre-release version of 3D InterOp on Linux ARM.
About Spatial Corp.
Spatial Corp, a Dassault Systèmes subsidiary, is the leading provider of 3D software development toolkits for technical applications across a broad range of industries. Spatial 3D modeling, 3D visualization, and CAD translation software development toolkits help application developers deliver market-leading products, maintain focus on core competencies, and reduce time-to-market. For over 35 years, Spatial’s 3D software development toolkits have been adopted by many of the world’s most recognized software developers, manufacturers, research institutes, and universities. Headquartered in Broomfield, Colorado, Spatial has offices in the USA, France, Germany, Japan, China, and the United Kingdom. For more information on Spatial’s latest updates and product offerings, please visit www.spatial.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241118352204/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press release
The Phase 3 frontMIND study evaluated tafasitamab (Monjuvi®/Minjuvi®) and lenalidomide in addition to R-CHOP, the current standard of care, compared with R-CHOP alone in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL)Positive trends toward progression-free survival (PFS) benefit with tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypesThe frontMIND data support the submission of global regulatory applications for tafasitamab and lenalidomide added to R-CHOP for previously untreated DLBCLThe data are being presented in an oral session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in The Lancet* Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating t
Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom